+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search in Lung Cancer Drugs returned 284 results.

From
Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Research Report on China's Gefitinib Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Gefitinib Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Research Report on China's Exemestane Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Exemestane Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
From
Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
HER2 Lung Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER2 Lung Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Gemcitabine HCL Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gemcitabine HCL Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Doxorubicin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Doxorubicin Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Loading Indicator